多发性-话题@MedSci

#多发性#

905篇内容 | 2930人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1889981, encodeId=dce91889981fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NATURE：人类多发性硬化症中少突胶质细胞异质性改变, objectType=article, longId=160001, objectId=d82116000102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82116000102, replyNumber=0, likeNumber=72, createdTime=2019-09-19, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82116000102, moduleTitle=NATURE：人类多发性硬化症中少突胶质细胞异质性改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82116000102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889978, encodeId=bbad18899e8c0, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：他汀类药物不会增加多发性神经病的风险, objectType=article, longId=159747, objectId=d901159e4769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d901159e4769, replyNumber=0, likeNumber=77, createdTime=2019-09-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d901159e4769, moduleTitle=Neurology：他汀类药物不会增加多发性神经病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d901159e4769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890027, encodeId=be81189002e53, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NCCN临床实践指南：多发性骨髓瘤（2019.V3）, objectType=article, longId=172211, objectId=146a1e2211b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146a1e2211b1, replyNumber=0, likeNumber=39, createdTime=2020-01-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146a1e2211b1, moduleTitle=NCCN临床实践指南：多发性骨髓瘤（2019.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146a1e2211b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889992, encodeId=49d11889992be, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性颅内动脉瘤1例, objectType=article, longId=161795, objectId=92e0161e9582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e0161e9582, replyNumber=0, likeNumber=83, createdTime=2019-12-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e0161e9582, moduleTitle=多发性颅内动脉瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e0161e9582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889940, encodeId=d40b18899405f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较, objectType=article, longId=148777, objectId=3e5c148e7712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5c148e7712, replyNumber=0, likeNumber=76, createdTime=2018-10-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5c148e7712, moduleTitle=NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5c148e7712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890008, encodeId=47e718900087d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：儿童发病的多发性硬化症患者长期残疾进展, objectType=article, longId=166279, objectId=80701662e905, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80701662e905, replyNumber=0, likeNumber=72, createdTime=2019-12-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80701662e905, moduleTitle=Neurology：儿童发病的多发性硬化症患者长期残疾进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80701662e905)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889956, encodeId=048d18899564b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：体重指数与多发性硬化患者脑容量变化有关, objectType=article, longId=153608, objectId=d3c715360844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3c715360844, replyNumber=0, likeNumber=74, createdTime=2019-08-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3c715360844, moduleTitle=Neurology：体重指数与多发性硬化患者脑容量变化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3c715360844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889976, encodeId=8cb918899e636, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：UAE抑制剂有望克服多发性骨髓瘤素来已久的耐药性！, objectType=article, longId=159704, objectId=2325159e0464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2325159e0464, replyNumber=0, likeNumber=56, createdTime=2019-03-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2325159e0464, moduleTitle=Blood：UAE抑制剂有望克服多发性骨髓瘤素来已久的耐药性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2325159e0464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889997, encodeId=5cab188999e11, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：3期CLARION研究：卡非佐米和硼替佐米治疗新确诊的多发性骨髓瘤的疗效和安全性对比, objectType=article, longId=163558, objectId=50f7163558ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50f7163558ca, replyNumber=0, likeNumber=83, createdTime=2019-09-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50f7163558ca, moduleTitle=Blood：3期CLARION研究：卡非佐米和硼替佐米治疗新确诊的多发性骨髓瘤的疗效和安全性对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50f7163558ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890009, encodeId=e3871890009a1, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Celgene以来那度胺和泊马度胺为基础的三联组合方案，获得欧盟委员会批准用于治疗多发性骨髓瘤, objectType=article, longId=166284, objectId=6d3416628417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d3416628417, replyNumber=0, likeNumber=84, createdTime=2020-04-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d3416628417, moduleTitle=Celgene以来那度胺和泊马度胺为基础的三联组合方案，获得欧盟委员会批准用于治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d3416628417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889974, encodeId=1d9118899e473, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Nat Commun：多发性硬化症——通过帮助细胞来帮助自己, objectType=article, longId=159265, objectId=feb9159265ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feb9159265ae, replyNumber=0, likeNumber=97, createdTime=2019-06-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feb9159265ae, moduleTitle=Nat Commun：多发性硬化症——通过帮助细胞来帮助自己, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feb9159265ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889912, encodeId=78f71889912e2, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：3T MRI不会增加多发性硬化诊断的灵敏度, objectType=article, longId=141253, objectId=0cf9141253f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cf9141253f6, replyNumber=0, likeNumber=57, createdTime=2019-05-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cf9141253f6, moduleTitle=Neurology：3T MRI不会增加多发性硬化诊断的灵敏度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cf9141253f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889984, encodeId=f7d5188998459, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, objectType=article, longId=160233, objectId=01b116023331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b116023331, replyNumber=0, likeNumber=69, createdTime=2019-04-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b116023331, moduleTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01b116023331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889960, encodeId=3c70188996085, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：卡非佐米相比硼替佐米可延长复发性/难治性多发性骨髓瘤患者的无进展存活期和总体存活期，且不受基础肾功能影响, objectType=article, longId=154529, objectId=b94515452947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94515452947, replyNumber=0, likeNumber=72, createdTime=2019-05-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94515452947, moduleTitle=Blood：卡非佐米相比硼替佐米可延长复发性/难治性多发性骨髓瘤患者的无进展存活期和总体存活期，且不受基础肾功能影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b94515452947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889945, encodeId=2646188994592, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=上颌骨肿块为首发症状的多发性骨髓瘤1例, objectType=article, longId=150916, objectId=f350150916d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f350150916d1, replyNumber=0, likeNumber=0, createdTime=2019-09-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f350150916d1, moduleTitle=上颌骨肿块为首发症状的多发性骨髓瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f350150916d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889999, encodeId=61221889999e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, objectType=article, longId=164344, objectId=ad231643441f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad231643441f, replyNumber=0, likeNumber=57, createdTime=2019-11-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad231643441f, moduleTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad231643441f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889949, encodeId=94c818899492e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=【2018 CSH】蔡真教授：多发性骨髓瘤的治疗现状与分层治疗策略, objectType=article, longId=152392, objectId=05c515239275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05c515239275, replyNumber=0, likeNumber=88, createdTime=2019-03-19, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05c515239275, moduleTitle=【2018 CSH】蔡真教授：多发性骨髓瘤的治疗现状与分层治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05c515239275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889908, encodeId=18dd1889908b3, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=CLIN CANCER RES：血小板通过上调IL-1β促进多发性骨髓瘤进展, objectType=article, longId=140219, objectId=063414021947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063414021947, replyNumber=0, likeNumber=61, createdTime=2019-03-22, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063414021947, moduleTitle=CLIN CANCER RES：血小板通过上调IL-1β促进多发性骨髓瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063414021947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889983, encodeId=fff3188998329, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Ann Rheum Dis： Florbetapir[18F]正电子发射断层扫描：包涵体肌炎中肌肉淀粉样蛋白的识别及与多发性肌炎的鉴别, objectType=article, longId=160148, objectId=e51416014876, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e51416014876, replyNumber=0, likeNumber=77, createdTime=2019-05-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e51416014876, moduleTitle=Ann Rheum Dis： Florbetapir[18F]正电子发射断层扫描：包涵体肌炎中肌肉淀粉样蛋白的识别及与多发性肌炎的鉴别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e51416014876)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889948, encodeId=7057188994855, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=得了多发性骨髓瘤吃什么好？吃什么不好？, objectType=article, longId=152143, objectId=4c8f152143a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c8f152143a7, replyNumber=0, likeNumber=0, createdTime=2018-11-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c8f152143a7, moduleTitle=得了多发性骨髓瘤吃什么好？吃什么不好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c8f152143a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NATURE：人类多发性硬化症中少突胶质细胞异质性改变

2019-09-19

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：他汀类药物不会增加多发性神经病的风险

2019-09-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NCCN临床实践指南：多发性骨髓瘤（2019.V3）

2020-01-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性颅内动脉瘤1例

2019-12-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NEJM：芬戈莫德与干扰素β-1a对儿童多发性硬化症的疗效比较

2018-10-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：儿童发病的多发性硬化症患者长期残疾进展

2019-12-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：体重指数与多发性硬化患者脑容量变化有关

2019-08-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：UAE抑制剂有望克服多发性骨髓瘤素来已久的耐药性！

2019-03-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：3期CLARION研究：卡非佐米和硼替佐米治疗新确诊的多发性骨髓瘤的疗效和安全性对比

2019-09-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Celgene以来那度胺和泊马度胺为基础的三联组合方案，获得欧盟委员会批准用于治疗多发性骨髓瘤

2020-04-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Nat Commun：多发性硬化症——通过帮助细胞来帮助自己

2019-06-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：3T MRI不会增加多发性硬化诊断的灵敏度

2019-05-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险

2019-04-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：卡非佐米相比硼替佐米可延长复发性/难治性多发性骨髓瘤患者的无进展存活期和总体存活期，且不受基础肾功能影响

2019-05-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

上颌骨肿块为首发症状的多发性骨髓瘤1例

2019-09-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用

2019-11-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

【2018 CSH】蔡真教授：多发性骨髓瘤的治疗现状与分层治疗策略

2019-03-19

jml2009 (审核中...)

前往app查看评论内容

#多发性#

CLIN CANCER RES：血小板通过上调IL-1β促进多发性骨髓瘤进展

2019-03-22

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Ann Rheum Dis： Florbetapir[18F]正电子发射断层扫描：包涵体肌炎中肌肉淀粉样蛋白的识别及与多发性肌炎的鉴别

2019-05-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

得了多发性骨髓瘤吃什么好？吃什么不好？

2018-11-06

科室
- - 订阅+
  - 更多科室
工具
服务